Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CCXI
Churchill Capital Corp XI
$10.25
0.0%
$0.00
$10.07
$11.00
$731.04M1.2218,835 shs6,792 shs
EVAC
EQV Ventures Acquisition Corp. II
$10.17
0.0%
$0.00
$9.90
$10.18
$594.14MN/A135,363 shs1,907 shs
IPFX
Inflection Point Acquisition Corp. VI
$10.00
+0.1%
$0.00
$9.95
$10.05
N/AN/A28,955 shs52,210 shs
SPCK
SPAC and New Issue ETF
$22.32
-0.1%
$0.00
$21.32
$26.61
$7.14M0.12,204 shs12,778 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CCXI
Churchill Capital Corp XI
-0.29%+0.24%+0.05%+1,024,999,900.00%+1,024,999,900.00%
EVAC
EQV Ventures Acquisition Corp. II
+0.05%+0.05%+0.35%+1,016,999,900.00%+1,016,999,900.00%
IPFX
Inflection Point Acquisition Corp. VI
+0.20%+0.20%+998,999,900.00%+998,999,900.00%+998,999,900.00%
SPCK
SPAC and New Issue ETF
-0.04%+2.00%+0.72%+2,238,999,900.00%+2,238,999,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CCXI
Churchill Capital Corp XI
$10.25
0.0%
$0.00
$10.07
$11.00
$731.04M1.2218,835 shs6,792 shs
EVAC
EQV Ventures Acquisition Corp. II
$10.17
0.0%
$0.00
$9.90
$10.18
$594.14MN/A135,363 shs1,907 shs
IPFX
Inflection Point Acquisition Corp. VI
$10.00
+0.1%
$0.00
$9.95
$10.05
N/AN/A28,955 shs52,210 shs
SPCK
SPAC and New Issue ETF
$22.32
-0.1%
$0.00
$21.32
$26.61
$7.14M0.12,204 shs12,778 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CCXI
Churchill Capital Corp XI
-0.29%+0.24%+0.05%+1,024,999,900.00%+1,024,999,900.00%
EVAC
EQV Ventures Acquisition Corp. II
+0.05%+0.05%+0.35%+1,016,999,900.00%+1,016,999,900.00%
IPFX
Inflection Point Acquisition Corp. VI
+0.20%+0.20%+998,999,900.00%+998,999,900.00%+998,999,900.00%
SPCK
SPAC and New Issue ETF
-0.04%+2.00%+0.72%+2,238,999,900.00%+2,238,999,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CCXI
Churchill Capital Corp XI
1.00
SellN/AN/A
EVAC
EQV Ventures Acquisition Corp. II
1.00
SellN/AN/A
IPFX
Inflection Point Acquisition Corp. VI
0.00
N/AN/AN/A
SPCK
SPAC and New Issue ETF
1.00
Strong Sell$22.32N/A

Current Analyst Ratings Breakdown

Latest SPCK, IPFX, CCXI, and EVAC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/6/2026
CCXI
Churchill Capital Corp XI
Initiated CoverageSell (E)
5/1/2026
EVAC
EQV Ventures Acquisition Corp. II
UpgradeSell (E+)Sell (D-)
4/7/2026
EVAC
EQV Ventures Acquisition Corp. II
Initiated CoverageSell (E+)
(Data available from 5/27/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CCXI
Churchill Capital Corp XI
$37.20M19.65N/AN/AN/A
EVAC
EQV Ventures Acquisition Corp. II
N/AN/A$0.15 per share66.64($0.28) per shareN/A
IPFX
Inflection Point Acquisition Corp. VI
N/AN/AN/AN/AN/AN/A
SPCK
SPAC and New Issue ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CCXI
Churchill Capital Corp XI
N/A-$1.89N/AN/AN/AN/AN/AN/AN/A
EVAC
EQV Ventures Acquisition Corp. II
$8.92MN/AN/AN/AN/AN/A-104.74%3.63%N/A
IPFX
Inflection Point Acquisition Corp. VI
N/AN/AN/AN/AN/AN/AN/AN/AN/A
SPCK
SPAC and New Issue ETF
N/AN/AN/AN/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
CCXI
Churchill Capital Corp XI
N/AN/AN/AN/AN/A
EVAC
EQV Ventures Acquisition Corp. II
N/AN/AN/AN/AN/A
IPFX
Inflection Point Acquisition Corp. VI
N/AN/AN/AN/AN/A
SPCK
SPAC and New Issue ETF
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CCXI
Churchill Capital Corp XI
N/AN/AN/A
EVAC
EQV Ventures Acquisition Corp. II
N/A
5.95
5.95
IPFX
Inflection Point Acquisition Corp. VI
N/AN/AN/A
SPCK
SPAC and New Issue ETF
N/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
CCXI
Churchill Capital Corp XI
N/A71.36 millionN/AN/A
EVAC
EQV Ventures Acquisition Corp. II
N/A58.45 millionN/AN/A
IPFX
Inflection Point Acquisition Corp. VI
N/AN/AN/AN/A
SPCK
SPAC and New Issue ETF
N/A320,000N/AN/A

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

Media Sentiment Over Time

Churchill Capital Corp XI NASDAQ:CCXI

$10.24 -0.01 (-0.05%)
As of 12:39 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Churchill Capital Corp XI is a blank check company.

EQV Ventures Acquisition Corp. II NYSE:EVAC

$10.16 -0.01 (-0.05%)
As of 12:48 PM Eastern
This is a fair market value price provided by Massive. Learn more.

EQV Ventures Acquisition Corp II is a blank check company.

Inflection Point Acquisition Corp. VI NASDAQ:IPFX

$9.99 +0.01 (+0.05%)
As of 01:06 PM Eastern
This is a fair market value price provided by Massive. Learn more.

SPAC and New Issue ETF NASDAQ:SPCK

$22.32 -0.03 (-0.11%)
As of 01:09 PM Eastern
This is a fair market value price provided by Massive. Learn more.